🇺🇸 oral anti-diabetic drug in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 3
Most-reported reactions
- Convulsion — 1 report (33.33%)
- Electroencephalogram Abnormal — 1 report (33.33%)
- Wrong Technique In Drug Usage Process — 1 report (33.33%)
Other Diabetes approved in United States
Frequently asked questions
Is oral anti-diabetic drug approved in United States?
oral anti-diabetic drug does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for oral anti-diabetic drug in United States?
Novo Nordisk A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.